Contents IX
II. Pharmacodynamic Therapy with Glucocorticoids (A) . . . . . . . . . . . 244 Androgens, Anabolic Steroids, Antiandrogens . . . . . . . . . . . . . . 248
Inhibitory Principles . . . . . . . . . . 248 Follicular Growth and Ovulation,
Estrogen and Progestin Production . . 250 Oral Contraceptives . . . . . . . . . . . 252 Antiestrogen and Antiprogestin
Active Principles . . . . . . . . . . . . . 254 Aromatase Inhibitors . . . . . . . . . . 256 Insulin Formulations . . . . . . . . . . . 258 Variations in Dosage Form . . . . . . 258 Variation in Amino Acid Sequence. . 258
Treatment of Insulin-dependent
Diabetes Mellitus. . . . . . . . . . . . . 260 Undesirable Effects . . . . . . . . . . 260
Treatment of Maturity-Onset
(Type II) Diabetes Mellitus. . . . . . . . 262 Oral Antidiabetics . . . . . . . . . . . . 264 Drugs for Maintaining Calcium
Homeostasis . . . . . . . . . . . . . . . 266
Antibacterial Drugs . . . . . . . . . . . 268
Drugs for Treating Bacterial
Infections . . . . . . . . . . . . . . . . . 268 Inhibitors of Cell Wall Synthesis . . . . 270 Inhibitors of Tetrahydrofolate
Synthesis . . . . . . . . . . . . . . . . . 274 Inhibitors of DNA Function . . . . . . . 276 Inhibitors of Protein Synthesis . . . . . 278 Drugs for Treating Mycobacterial
Infections . . . . . . . . . . . . . . . . . 282 Antitubercular drugs (1) . . . . . . . 282 Antileprotic drugs (2) . . . . . . . . . 282
Antifungal Drugs . . . . . . . . . . . . |
284 |
Drugs Used in the Treatment of
Fungal Infections . . . . . . . . . . . . . 284
Antiviral Drugs . . . . . . . . . . . . . . 286
Chemotherapy of Viral Infections. . . . 286 Drugs for the Treatment of AIDS . . . . 290
I. Inhibitors of Reverse Transcriptase—Nucleoside Agents . . 290 Nonnucleoside Inhibitors . . . . . . . 290 II. HIV protease Inhibitors . . . . . . . 290 III. Fusion Inhibitors . . . . . . . . . . 290
Antiparasitic Drugs . . . . . . . . . . . 292
Drugs for Treating Endoparasitic
and Ectoparasitic Infestations . . . . . . 292 Antimalarials . . . . . . . . . . . . . . . 294 Other Tropical Diseases . . . . . . . . . 296
Anticancer Drugs . . . . . . . . . . . . |
298 |
Chemotherapy of Malignant
Tumors . . . . . . . . . . . . . . . . . . 298 Targeting of Antineoplastic Drug
Action (A) . . . . . . . . . . . . . . . . . 302 Mechanisms of Resistance to
Cytostatics (B) . . . . . . . . . . . . . . 302
Immune Modulators . . . . . . . . . . 304
Inhibition of Immune Responses . . . . 304
Antidotes . . . . . . . . . . . . . . . . . 308
Antidotes and Treatment of
Poisonings. . . . . . . . . . . . . . . . . 308
Therapy of Selected Diseases |
|
313 |
|
Hypertension . . . . . . . . . . . . . . . |
314 |
Osteoporosis . . . . . . . . . . . . . . |
. 330 |
Angina Pectoris . . . . . . . . . . . . . |
316 |
Rheumatoid Arthritis. . . . . . . . . . . |
332 |
Antianginal Drugs . . . . . . . . . . . . |
318 |
Migraine . . . . . . . . . . . . . . . . . . |
334 |
Acute Coronary Syndrome— |
|
Common Cold . . . . . . . . . . . . . . |
336 |
Myocardial Infarction . . . . . . . . . . |
320 |
Atopy and Antiallergic Therapy . . . . . |
338 |
Congestive Heart Failure . . . . . . . . |
322 |
Bronchial Asthma. . . . . . . . . . . . . |
340 |
Hypotension . . . . . . . . . . . . . . . |
324 |
Emesis . . . . . . . . . . . . . . . . . . . |
342 |
Gout. . . . . . . . . . . . . . . . . . . . |
326 |
Alcohol Abuse. . . . . . . . . . . . . . . |
344 |
Obesity—Sequelae and |
|
Local Treatment of Glaucoma . . . . . . |
346 |
Therapeutic Approaches. . . . . . . . . |
328 |
|
|
X |
Contents |
|
|
Further Reading |
|
349 |
|
Drug Indexes |
|
351 |
|
Trade Name – Drug Name . . . . . . . |
352 Drug Name – Trade Name. . . . . . . |
. 369 |
|
Subject Index |
|
381 |
|